1. Yang R, Chen Z, Liang L, Ao S, Zhang J, Chang Z, Wang Z, Zhou Y, Duan X, Deng T*. Fc
Fragment of IgE Receptor Ig (FCER1G) acts as a key gene involved in cancer immune infiltration and
tumour microenvironment. Immunology. 2022 Aug 1. doi: 10.1111/imm.13557. Online ahead of print.
2. Deng T*, He Z, Duan X, Gu D, Cai C, Wu W, Liu Y, Zeng G. STAM Prolongs Clear Cell Renal
Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion. Front Oncol. 2021;11:611081.
3. Deng T, Zeng G*. Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death
Ligand 1 Inhibitors in Patients With Cancer. JAMA Oncol. 2020;6(7):1113-1114.
4. Deng T, Mai Z, Duan X, Zhao Z, Zhu W, Cai C, Wu W, Zeng G*. Association between
hypertension and 24-h urine composition in adults without urolithiasis in China. World J Urol.
2021;39(2):589-595.
5. Deng T, Chen Y, Liu B, Laguna MP, de la Rosette JJMCH, Duan X, Wu W, Zeng G*. Systematic
review and cumulative analysis of the managements for proximal impacted ureteral stones. World J Urol.
2019; 37(8):1687-1701.
6. Deng T, Liu B, Duan X, Cai C, Zhao Z, Zhu W, Fan J, Wu W, Zeng G*. Antibiotic prophylaxis in
ureteroscopic lithotripsy: a systematic review and meta-analysis of comparative studies. BJU Int. 2018;
122(1): 29-39.
7. Deng T, Liu B, Luo L, Duan X, Cai C, Zhao Z, Zhu W, Wu W, Zeng G*. Robot-assisted
laparoscopic versus open ureteral reimplantation for pediatric vesicoureteral reflux: a systematic review and
meta-analysis. World J Urol. 2018; 36(5): 819-828.
8. Deng T, Liu B, Duan X, Zhang T, Cai C, Zeng G*. Systematic Review and Cumulative Analysis of
the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non-Muscle-Invasive Bladder
Cancer. Sci Rep. 2017; 7(1): 3172.
9. Deng T, Liao B, Luo D, Shen H, Wang K*. Risk factors for mesh erosion after female pelvic floor
reconstructive surgery: a systematic review and meta-analysis. BJU Int. 2016; 117(2):323-43.
10. Kong Z#, Deng T#, Zhang M, Zhao Z, Liu Y, Luo L, Cai C, Wu W, Duan X*. β
-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo.
Cancer Sci. 2018; 109(6): 1834-1842.
代表性成果: